Related Articles
Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis
Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review)
Toxic epidermal necrolysis after injection of sclerosing agent and medical adhesive into oesophageal variceal ligation in a patient with a malignant liver tumour: A case report
Crizotinib-associated toxic epidermal necrolysis in an ALK-positive advanced NSCLC patient
Concomitance or consequence? Stevens‑Johnson syndrome in COVID‑19: A case report